Compare AbCellera Biologics Inc (ABCL) vs CubeSmart (CUBE) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs CubeSmart — how do they compare? AbCellera Biologics Inc trades at $7.18 (market cap $2.35B), while CubeSmart trades at $39.9 (market cap $9.26B). The key difference: CubeSmart is far larger — about 3.9× AbCellera Biologics Inc's market cap, and CubeSmart pays a 5.19% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | CUBE | |
|---|---|---|
Market Cap | $2.35B | $9.26B |
Sector | Health | Real Estate |
52-Week High | $8.12 | $42.60 |
52-Week Low | $2.78 | $35.36 |
Enterprise Value | $1.99B | $12.75B |
Dividend Yield | — | 5.19% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbCellera Biologics (ABCL) trades at $7.69, down 2.29% on the day, with strong analyst support (82% buy ratings) and a $9.67 consensus price target suggesting 26% upside. The stock shows bullish technical momentum with moving averages supporting the trend, though RSI levels indicate potential overbought conditions. Recent positive developments include a major $876 million collaboration with Jazz Pharmaceuticals and board expansions, offsetting concerns about negative cash flow and profitability metrics.
While ABCL faces significant fundamental challenges with negative margins and cash burn, the company's strong cash position ($626M) and recent strategic partnerships provide runway for growth. The primary investment thesis hinges on successful pipeline development and platform monetization, with risks centered on execution and path to profitability. Wall Street remains optimistic about the long-term platform value despite near-term financial headwinds.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About CubeSmart
CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Most of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. CubeSmart derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.
Read more on CUBE →
